LKFT
Lakefront Biotherapeutics NVNASDAQ
Healthcare • Biotechnology
Updated 1 day ago
Coverage limited
Factor tilt: Value-tilted Small Cap
$29.05-1.76%
Close Oct 13, 2026
- Market cap
- $1.94B
- 1 month
- +8.8%
- 3 months
- -1.5%
- 1 year
- —
- Dividend
- No dividends on record
- Short interest
- 3.3M sharessettled Sep 30, 2026 · -2.8% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if LKFT is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
18 top institutions tracked
as of 2026-Q2 (filed 2026-08-14)
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
77 filers reported a long position in LKFT for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| GILEAD SCIENCES, INC. | $500.2M | 16.7M | Unchanged |
| TANG CAPITAL MANAGEMENT LLC | $113.5M | 3.8M | Unchanged |
| Madison Avenue Partners, LP | $103.4M | 3.4M | +39.9% |
| Prosight Management, LP | $61.3M | 2M | +31.8% |
| EcoR1 Capital, LLC | $50M | 1.7M | Unchanged |
| AMERIPRISE FINANCIAL INC | $38.1M | 1.3M | -10.7% |
| DME Capital Management, LP | $14.5M | 482.7K | Unchanged |
| RENAISSANCE TECHNOLOGIES LLC | $12.2M | 407.8K | +29.3% |
| BlackRock, Inc. | $10.1M | 338.2K | +8.3% |
| Point72 Asset Management, L.P. | $8.1M | 269.8K | -18.8% |
Get the Full Analysis for LKFT
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.